课题基金 / 基金详情

ALKALOID SYNTHESIS VIA (3+2) CYCLOADDITIONS

ALKALOID SYNTHESIS VIA (3+2) CYCLOADDITIONS
通过 (3 2) 环加成物合成生物碱
批准号:
6519643
负责人:
William H. Pearson
金额:
$24.16万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-01 至 2004-02-28

项目摘要

项目成果

William H. Pearson的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(首席研究员摘要)本研究的主要目的
英文摘要
DESCRIPTION: (Principal Investigator's Abstract) The principal objective of the proposed research is to continue to develop general and efficient methods for the synthesis of pyrrolidine-containing molecules of biological significance. A general synthetic method may be useful for the preparation of a wide variety of target molecules rather than a single class. The proposed research will attempt to use the anionic (3+2) cycloaddition of 2-azaallyl anions with alkenes and the 1,3-dipolar cycloaddition of azomethine ylides with alkenes for the construction of a cross-section of biologically relevant target molecules. The 2-azaallyl anions are prepared by tin-lithium exchange on (2-azaallyl)stannanes. The same (2-azaallyl)stannanes are also precursors of several novel types of non-stabilized azomethine ylides, which are also capable of (3+2) cycloadditions to produce pyrrolidines. These two types of reactive intermediates are proving to be complementary in their reactivity and diastereoselectivity. Applications of these methods to the synthesis of biologically interesting molecules is proposed in order to provide a context for methodology development. Each example is meant to test a different aspect of the (3+2) methodology. Targets include: (1) monomorine 1, the trail pheromone of the pharoah ant, (2) pictamine, a novel quinolizidine alkaloid isolated from tunicates with antimicrobial, antifungal, and antitumor activity, (3) lundurines B and C, isolated from Kopsia, the extracts of which find medicinal use for rheumatoid arthritis, dropsy, and tonsillitis in China, (4) 7-epiaustraline, a highly hydroxylated pyrrolizidine alkaloid with a unique hydroxymethyl group, a member of a class of such alkaloids that have activity as glucosidase I inhibitors, antiviral agents and antiretroviral agents, (5) scandine, a component of a Chinese folk medicine used for the treatment of rheumatic heart disease, and (6) erycibelline, a member of the tropane class of alkaloids. These targets will allow examination of the scope of the 2-azaallyl anion and azomethine ylide cycloaddition methods in several ways. For example, the types of anions or ylides required are diverse (e.g., simple aliphatic substituents, functionalized side chains, heterosubstituted versions, more conjugated versions, and cyclic versions), each with their unique chemistry and method of preparation. The issues of regiocontrol and stereocontrol, both absolute and relative, must be addressed. Tandem processes that involve the combination of (3+2) cycloaddition followed by additional reactions that lead to a second or third ring formation or a rearrangement are also being studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improved Method for the Purification of Oligonucleotides
  • 批准号:
    6788544
  • 项目类别:
  • 资助金额:
    $9.94万
  • 财政年份:
    2004
  • 负责人:
    William H. Pearson
  • 依托单位:
Purification of Oligonucleotides and Nucleoside Triphosphates
  • 批准号:
    7228929
  • 项目类别:
  • 资助金额:
    $31.06万
  • 财政年份:
    2004
  • 负责人:
    William H. Pearson
  • 依托单位:
Purification of Oligonucleotides and Nucleoside Triphosphates
  • 批准号:
    7109717
  • 项目类别:
  • 资助金额:
    $43.33万
  • 财政年份:
    2004
  • 负责人:
    William H. Pearson
  • 依托单位:
Purification of Optically Labeled Oligonucleotides
  • 批准号:
    6833405
  • 项目类别:
  • 资助金额:
    $9.98万
  • 财政年份:
    2004
  • 负责人:
    William H. Pearson
  • 依托单位:
海外基金